146 related articles for article (PubMed ID: 33822195)
1. Prognostication for meningiomas: H3K27me3 to the rescue?
Santagata S; Ligon KL
Neuro Oncol; 2021 Aug; 23(8):1218-1219. PubMed ID: 33822195
[No Abstract] [Full Text] [Related]
2. Proliferation in meningiomas: Introducing objectivity in assessment.
Chaturvedi S; Suri V
Neurol India; 2017; 65(6):1239-1240. PubMed ID: 29133693
[No Abstract] [Full Text] [Related]
3. Meningiomas: Objective assessment of proliferative indices by immunohistochemistry and automated counting method.
Jaiswal S
Neurol India; 2017; 65(6):1236-1238. PubMed ID: 29133692
[No Abstract] [Full Text] [Related]
4. The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma.
Jung M; Kim SI; Lim KY; Bae J; Park CK; Choi SH; Park SH; Won JK
Hum Pathol; 2021 Sep; 115():96-103. PubMed ID: 34186055
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.
Gauchotte G; Peyre M; Pouget C; Cazals-Hatem D; Polivka M; Rech F; Varlet P; Loiseau H; Lacomme S; Mokhtari K; Kalamarides M; Bielle F
J Neuropathol Exp Neurol; 2020 Jul; 79(7):754-762. PubMed ID: 32447376
[TBL] [Abstract][Full Text] [Related]
6. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F
Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952
[TBL] [Abstract][Full Text] [Related]
7. High throughput screening of meningioma biomarkers using a tissue microarray.
Lusis EA; Chicoine MR; Perry A
J Neurooncol; 2005 Jul; 73(3):219-23. PubMed ID: 15980972
[TBL] [Abstract][Full Text] [Related]
8. Geniculate ganglion meningiomas: CT and MR appearances.
Larson TL; Talbot JM; Wong ML
AJNR Am J Neuroradiol; 1995 May; 16(5):1144-6. PubMed ID: 7639141
[No Abstract] [Full Text] [Related]
9. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas - prognostic biomarkers for routine practice.
Samal S; Patnaik A; Sahu F; Purkait S
Folia Neuropathol; 2020; 58(2):133-142. PubMed ID: 32729292
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging (MRI) Differential Diagnosis of Meningiomas Using ANOVA.
Liu J; Chen J; Zha Y; Huang Y; Zeng F
Contrast Media Mol Imaging; 2021; 2021():4799116. PubMed ID: 34354552
[TBL] [Abstract][Full Text] [Related]
12. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma.
Yue Q; Isobe T; Shibata Y; Anno I; Kawamura H; Yamamoto Y; Takano S; Matsumura A
Eur Radiol; 2008 Dec; 18(12):2901-11. PubMed ID: 18641997
[TBL] [Abstract][Full Text] [Related]
13. Circulating glycoconjugates in CSF of meningioma patients.
Davidsson P; Fredman P; von Holst H; Wikstrand CJ; He X; Bigner DD; Svennerholm L
Acta Neurol Scand; 1990 Sep; 82(3):203-8. PubMed ID: 2270748
[TBL] [Abstract][Full Text] [Related]
14. Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.
Hui M; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
J Postgrad Med; 2015; 61(1):32-5. PubMed ID: 25511215
[TBL] [Abstract][Full Text] [Related]
15. Dual use of E-cadherin and D2-40 immunostaining in unusual meningioma subtypes.
Mrachek EK; Davis D; Kleinschmidt-DeMasters BK
Am J Clin Pathol; 2015 Dec; 144(6):923-34. PubMed ID: 26573000
[TBL] [Abstract][Full Text] [Related]
16. Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature.
Elbabaa SK; Gokden M; Crawford JR; Kesari S; Saad AG
J Neurosurg Pediatr; 2012 Oct; 10(4):281-90. PubMed ID: 22900483
[TBL] [Abstract][Full Text] [Related]
17. Cervical spine chordoid meningioma. Case report.
Ibrahim A; Galloway M; Leung C; Revesz T; Crockard A
J Neurosurg Spine; 2005 Feb; 2(2):195-8. PubMed ID: 15739533
[TBL] [Abstract][Full Text] [Related]
18. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
Pfisterer WK; Nieman RA; Scheck AC; Coons SW; Spetzler RF; Preul MC
Neurosurg Focus; 2010 Jan; 28(1):E12. PubMed ID: 20043716
[TBL] [Abstract][Full Text] [Related]
19. Atypical meningiomas.
Chen R; Aghi MK
Handb Clin Neurol; 2020; 170():233-244. PubMed ID: 32586495
[TBL] [Abstract][Full Text] [Related]
20. Meningiomas: An Update on Diagnostic and Therapeutic Approaches.
Zada G; Jensen RL
Neurosurg Clin N Am; 2016 Apr; 27(2):xiii. PubMed ID: 27012390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
